Video Channel of China Longilat Bio Co., Ltd
Μας ελάτε σε επαφή με
Home Βίντεο Playlist Website

Cat Fipv Api Pharmaceutical Gs-441524 Injection Cat Feline Infectious Peritonitis

Other Videos
June 06, 2022
Category Connection: Gs-441524
Μας ελάτε σε επαφή με
Tags:
#Γάτα FIPV gs-441524 #Gs-441524 ταμπλέτες #200-001-8 gs-441524
Brief: Follow the narrative to see how small design choices affect everyday performance. In this video, we demonstrate the application and mechanism of GS-441524 injection for Feline Infectious Peritonitis research. You'll learn about proper dosing protocols for different FIP forms and see how this antiviral disrupts viral RNA replication in cats.
Related Product Features:
  • Strongly inhibits Feline Infectious Peritonitis Virus (FIPV) with high purity GS-441524 formulation.
  • Available as transparent liquid, powder, or tablets with 99.5% minimum purity standard.
  • Offers multiple concentration options including 15mg/ml and 20mg/ml in 5.5ml vials.
  • Designed specifically for CAT FIP research and development use only.
  • Provides detailed dosing guidelines for wet, dry, ocular, and neurological FIP cases.
  • Works through intracellular triple-phosphorylation to disrupt viral RNA replication.
  • Features fast delivery service for research and development requirements.
  • Compatible with both injection and emerging oral treatment methodologies.
Ερωτήσεις:
  • What is GS-441524 and how does it work?
    GS-441524 is an experimental antiviral drug that inhibits Feline Infectious Peritonitis Virus. It works through intracellular triple-phosphorylation to create an active adenosine triphosphate analogue that disrupts viral RNA replication by competing with endogenous NTPs and triggering chain termination.
  • What are the recommended treatment duration and dosing guidelines?
    Treatment typically requires a minimum of 12 weeks of daily subcutaneous injections. Dosing varies by FIP type: wet FIP requires 6-7 mg/kg, dry FIP 7-8 mg/kg, ocular or neuro FIP 8 mg/kg minimum, with increased cases requiring 9 mg/kg and maximum cases up to 10 mg/kg.
  • What are the known side effects and administration considerations?
    The primary side effects include pain during injections and potential skin lesions at injection sites. Injections should be given subcutaneously every 24 hours using appropriate syringe and needle sizes, with veterinary guidance recommended for initial administration.
  • Is oral treatment available and how does it compare to injections?
    Oral pills are available as an alternative treatment option, with each pill containing 10mg of GS-441524. However, oral versions are not yet widely available and neurological cases require specific dosage calculations that should be discussed directly with suppliers.
Related Videos